Analyst Update: 3M Stock's Price Target Revised with 20% Upside Potential
Friday, 19 April 2024, 15:18
Why the price target changed
Despite seemingly lower price target, reflects spin off of 3M's healthcare business now as Solventum. Analyst's revised target after spinoff signifies upgraded outlook.
Analyst update impact
Analyst's upbeat target contrasts other firms' cautious stance. Concerns over dividend cuts and legal settlements weigh on stock's outlook.
Investment decision
Considering operational challenges and ongoing legal issues, cautious approach advised.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.